Skip to content

Substance use initiation: The role of simultaneous polysubstance use

Janine V. Olthuis, Christine Darredeau, Sean P. Barrett

Drug and Alcohol Review May 21, 2012 DOI: 10.1111/j.1465-3362.2012.00470.x via OpenAlex

Summary

AI-generated from the abstract

Among 226 cannabis users, most first-time use of harder illicit drugs—including cocaine, amphetamines, MDMA, heroin, and hallucinogens—involved simultaneous use of other substances, with at least 75% of participants reporting co-administration. Alcohol, tobacco, or cannabis were the substances most often used alongside the new drug. First-time use of alcohol, tobacco, and cannabis itself showed less simultaneous polysubstance use. The findings suggest that episodes involving alcohol, tobacco, or cannabis may directly facilitate the initiation of new substance use, pointing to potential risk factors for substance use progression.

Study at a glance

Characteristics Cross-sectional study Peer reviewed
Sample size 226
Population Cannabis users
Topics Cannabis MDMA Mescaline Psilocybin
Keywords Polysubstance dependence Psychiatry
Citations 79
Key finding A clear majority of cannabis users (≥75%) reported simultaneous polysubstance use during their first-ever use of most illicit substances, with alcohol, tobacco, or cannabis commonly co-administered.

Abstract

Abstract Introduction and Aims. Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about its role in substance use initiation. Design and Methods. In the present study, 226 cannabis users completed structured interviews about their substance use history. For each substance ever used, participants provided details of their age of first use, their use in the preceding 30 days and whether they co‐administered any other licit or illicit substances the first time they used the substance. Results. For most illicit substances [powder cocaine, crack, amphetamine, methamphetamine, 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy), heroin, opium, gamma‐hydroxybutyric acid (GHB), ketamine, psilocybin (magic mushrooms), mescaline, phencyclidine (PCP), peyote and inhalants], results showed that a clear majority of participants ( ≥ 75%) reported SPU during their first‐ever use of the substance. While SPU was less common on occasions of first use of alcohol, tobacco and cannabis, a high proportion of SPU on occasions of first use of ‘harder’ drugs could be accounted for by the co‐use of alcohol, tobacco and/or cannabis. Discussion and Conclusions. Such findings raise the possibility that specific alcohol, tobacco and/or cannabis use episodes might directly contribute to the initiation of new substance use. Understanding the role of SPU on occasions of first use might help better identify risk factors for substance use progression and improve intervention efforts. [Olthuis JV, Darredeau C, Barrett SP. Substance use initiation: The role of simultaneous polysubstance use. Drug Alcohol Rev 2013;32:67–71]

Explore topics

Comments

No comments yet.

Log in to comment